HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 20 filers reported holding HEMISPHERX BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $624,000 | -13.3% | 5,414,581 | 0.0% | 0.00% | – |
| Q1 2016 | $720,000 | +62.5% | 5,414,581 | -1.6% | 0.00% | – |
| Q4 2015 | $443,000 | -99.7% | 5,503,182 | -64.3% | 0.00% | -100.0% |
| Q3 2015 | $134,405,000 | +11638.4% | 15,403,174 | +175.0% | 0.01% | – |
| Q2 2015 | $1,145,000 | -5.1% | 5,600,318 | +5.8% | 0.00% | – |
| Q1 2015 | $1,207,000 | -6.2% | 5,295,640 | +2.9% | 0.00% | – |
| Q4 2014 | $1,287,000 | -20.7% | 5,148,046 | +1.9% | 0.00% | – |
| Q3 2014 | $1,622,000 | +9.7% | 5,054,053 | +6.0% | 0.00% | – |
| Q2 2014 | $1,479,000 | -18.1% | 4,769,253 | +5.7% | 0.00% | – |
| Q1 2014 | $1,805,000 | +92.4% | 4,511,166 | +27.3% | 0.00% | – |
| Q4 2013 | $938,000 | +9.6% | 3,542,678 | -2.7% | 0.00% | – |
| Q3 2013 | $856,000 | +5.5% | 3,639,309 | 0.0% | 0.00% | – |
| Q2 2013 | $811,000 | – | 3,639,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 190,000 | $521,000 | 0.65% |
| WEDBUSH SECURITIES INC | 80,000 | $18,000 | 0.00% |
| CITY HOLDING CO | 5,000 | $1,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 290,000 | $66,120,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 20,792 | $4,000 | 0.00% |
| NORTHERN TRUST CORP | 235,051 | $53,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 897,977 | $204,000 | 0.00% |
| STATE STREET CORP | 81,000 | $18,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 37,501 | $9,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 24,735 | $6,000 | 0.00% |